NICE turns down Bayer’s Stivarga for liver cancer
admin 8th November 2017 Uncategorised 0Bayer’s Stivarga is not being recommended by NHS treatment cost regulators for certain patients with advanced unresectable hepatocellular carcinoma.
More: NICE turns down Bayer’s Stivarga for liver cancer
Source: News